tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

SLS Stock Latest News

Promising Phase 2a Trial Results and Upcoming Catalysts Drive Buy Rating for SELLAS Life Sciences Group
RatingsPromising Phase 2a Trial Results and Upcoming Catalysts Drive Buy Rating for SELLAS Life Sciences Group
7d ago
SLS
Sellas Life Sciences announces OS data in Cohort 3 from Phase 2 SLS009 trial
PremiumThe Fly
Sellas Life Sciences announces OS data in Cohort 3 from Phase 2 SLS009 trial
8d ago
SLS
Sellas Life Sciences Advances in Cancer Treatment Development
PremiumCompany Announcements
Sellas Life Sciences Advances in Cancer Treatment Development
20d ago
SLS
Promising Clinical Advancements and Financial Stability Position SELLAS Life Sciences Group for Growth
PremiumRatings
Promising Clinical Advancements and Financial Stability Position SELLAS Life Sciences Group for Growth
22d ago
SLS
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
27d ago
PLX
SLS
Is SLS a Buy, Before Earnings?
PremiumPre-EarningsIs SLS a Buy, Before Earnings?
29d ago
SLS
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
FRO
SLS
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
HUM
NOC
Promising Outlook for SELLAS Life Sciences: Positive Trial Results and Financial Stability Support ‘Buy’ Rating
PremiumRatings
Promising Outlook for SELLAS Life Sciences: Positive Trial Results and Financial Stability Support ‘Buy’ Rating
2M ago
SLS
Sellas Life Sciences’ zanubrutinib combination shows efficacy in DLBCL
PremiumThe Fly
Sellas Life Sciences’ zanubrutinib combination shows efficacy in DLBCL
2M ago
SLS
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
2M ago
MCY
SLS
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
2M ago
TM
CAH
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
3M ago
DNA
FAZ
Sellas $25M registered direct offering priced at $1.27 per share and warrant
Premium
The Fly
Sellas $25M registered direct offering priced at $1.27 per share and warrant
3M ago
SLS
SELLAS Life Sciences Announces Positive Phase 3 Trial Results
Premium
Company Announcements
SELLAS Life Sciences Announces Positive Phase 3 Trial Results
3M ago
8K
SLS
Sellas Life Sciences announces IDMC completed interim analysis of REGAL trial
PremiumThe Fly
Sellas Life Sciences announces IDMC completed interim analysis of REGAL trial
3M ago
SLS
SELLAS Life Sciences Amends Severance for Key Executives
PremiumCompany Announcements
SELLAS Life Sciences Amends Severance for Key Executives
3M ago
8K
SLS
Sellas Life Sciences announces key business objecives for 2025
PremiumThe Fly
Sellas Life Sciences announces key business objecives for 2025
3M ago
SLS
SELLAS Life Sciences Advances Phase 3 AML Trial
PremiumCompany Announcements
SELLAS Life Sciences Advances Phase 3 AML Trial
4M ago
8K
SLS
Sellas Life Sciences triggers interim analysis in Phase 3 REGAL trial
PremiumThe FlySellas Life Sciences triggers interim analysis in Phase 3 REGAL trial
4M ago
SLS
Sellas Life Sciences reports OS, ORR data from Phase 2 trial of SLS009
Premium
The Fly
Sellas Life Sciences reports OS, ORR data from Phase 2 trial of SLS009
4M ago
SLS
Sellas Life Sciences announces data from preclinical studies of SLS009
Premium
The Fly
Sellas Life Sciences announces data from preclinical studies of SLS009
5M ago
SLS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >